Back to top
more

Henry Schein (HSIC)

(Real Time Quote from BATS)

$70.53 USD

70.53
589,464

-1.80 (-2.49%)

Updated Nov 5, 2024 10:32 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks News

Fresenius Medical (FMS) Launches Campaign to Boost Kidney Care

Fresenius Medical's (FMS) My Reason campaign will help scientists understand genetic variations in patients with chronic kidney disease in a better way.

Here's Why You Should Retain Phibro (PAHC) Stock For Now

Investors are optimistic about Phibro (PAHC) owing to the robust performances by its Animal Health and Mineral Health segments.

The Zacks Analyst Blog Highlights Splunk, Vertex Pharmaceuticals, Henry Schein, Jack Henry & Associates, and Check Point Software Technologies

Splunk, Vertex Pharmaceuticals, Henry Schein, Jack Henry & Associates, and Check Point Software Technologies are part of Top Analyst Blog.

Integer Holdings' (ITGR) Latest Buyout to Expand Its Footprint

Integer Holdings' (ITGR) buyout of Aran Biomedical is set to expand its presence in high-growth markets as well as enhance its product offerings.

Masimo's (MASI) Sound United Buyout to Boost Product Portfolio

Masimo's (MASI) completion of Sound United's buyout to help enhance the former's extended portfolio of hospital and home medical technology solutions.

Nalak Das headshot

Top 5 High-Flying Nasdaq Stocks Amid Index's YTD Meltdown

We have narrowed our search to five Nasdaq listed stocks that have witnessed double-digit rally year to date. These are: VRTX, SPLK, HSIC, CHKP and JKHY.

Merit Medical's (MMSI) SCOUT Bx Delivery System Gets FDA Nod

Merit Medical's (MMSI) receipt of FDA clearance for the SCOUT Bx system can streamline treatment for cancer patients.

Quidel Corporation (QDEL) Reports Solid Preliminary Q1 Revenues

Quidel's (QDEL) revenue growth in the first quarter is likely to have been boosted by continued robust sales of its SARS-related products.

Abiomed (ABMD) Announces Successful Usage of Impella in Japan

Continued adoption of Abiomed's (ABMD) Impella 5.5 with SmartAssist is likely to provide a minimally invasive surgical option for acute heart failure patients.

Cardinal Health (CAH) Hits 52-Week High: What's Aiding It?

Investors are optimistic about Cardinal Health's (CAH) diversified product portfolio.

AmerisourceBergen's (ABC) Venture Capital Fund to Aid Healthcare

AmerisourceBergen's (ABC) new corporate venture capital fund to help emerging healthcare startup companies change healthcare for people and animals globally.

Here's Why You Should Retain West Pharmaceutical (WST) Now

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.

Henry Schein (HSIC) Hits a New 52-Week High: What's Driving It?

Investors are optimistic about Henry Schein (HSIC) owing to favorable dental business trends and a strong solvency position.

AmerisourceBergen (ABC) Hits 52-Week High: What's Aiding It?

Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.

Here's Why You Should Invest In Henry Schein (HSIC) Now

Investors are optimistic about Henry Schein (HSIC) owing to the favorable dental business trends.

PerkinElmer (PKI) Boosts In Vivo Imaging Profile With New System

PerkinElmer's (PKI) launch of the Vega imaging system is likely to help the company expand its in vivo imaging portfolio.

PerkinElmer's (PKI) New Assay Kits to Detect CHO HCP Impurities

PerkinElmer (PKI) launches ready-to-use HTRF and AlphaLISA no-wash assay kits to quickly identify and quantify CHO HCP impurities.

Catalent's (CTLT) Latest Buyout to Expand Its Global Footprint

Catalent's (CTLT) latest acquisition is likely to significantly enhance its global Biologics business.

Baxter's (BAX) ST Set Receives FDA Nod, to Boost Patient Outcome

Baxter's (BAX) ST Set is expected to improve treatments in an acute care environment.

Here's Why You Should Retain Cooper Companies (COO) Stock Now

Cooper Companies (COO) continues to benefit from strength in its business segments.

Here's Why You Should Retain Merit Medical (MMSI) Stock For Now

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

Shockwave Medical's (SWAV) New Launch to Lower IVL Treatment Time

Shockwave Medical's (SWAV) latest global commercial launch is expected to serve a more diverse patient pool.

DexCom's (DXCM) Upcoming Launch to Boost Diabetes Management

DexCom's (DXCM) upcoming launch of Dexcom ONE CGM can help people in the U.K. to manage diabetes.

Here's Why You Should Hold on to Stryker (SYK) Stock for Now

Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure remains a concern.

Accuray's (ARAY) CyberKnife Effective for Relief From TN Pain

Latest data indicates that Accuray's (ARAY) CyberKnife System is effective in providing long-lasting pain relief to patients suffering from TN.